Wave Life Sciences (WVE) Capital Expenditures (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Capital Expenditures data on file, last reported at $884000.0 in Q2 2026.

• Quarterly Capital Expenditures rose 188.89% year-over-year to $884000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 million (up 66.91% YoY) and the FY2025 annual result came in at $718000.0, down 23.45% from the prior year.
• Capital Expenditures climbed to $884000.0 in Q2 2026, from $438000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $884000.0 in Q2 2026 to a low of -$1000.0 in Q4 2025.
• A 5-year average of $303000.0 and a median of $277000.0 in 2025 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures surged 1260.0% — and 2025, when it sank 101.16%.
• Tracing WVE's Capital Expenditures over 5 years: stood at $204000.0 in 2022, then jumped by 74.51% to $356000.0 in 2023, then plunged by 75.84% to $86000.0 in 2024, then slumped by 101.16% to -$1000.0 in 2025, then jumped by 88500.0% to $884000.0 in 2026.
• The last three Capital Expenditures figures came in at $884000.0 (Q2 2026), $438000.0 (Q1 2026), and -$1000.0 (Q4 2025), per Business Quant data.